Matches in SemOpenAlex for { <https://semopenalex.org/work/W1787686503> ?p ?o ?g. }
- W1787686503 endingPage "174" @default.
- W1787686503 startingPage "171" @default.
- W1787686503 abstract "Background: Considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. The objective of this study was to assess the safety, efficacy and non inferiority of Safacto (Recombinant factor VIII) compared with plasma-derived factor in the treatment of hemophilia A. Methods: 10 patients with severe hemophilia A were enrolled in this study. Each patient was treated by a 40-50 IU/kg infusion of either plasma derived or recombinant factor VIII after initiation of each of 4 consecutive hemarthrosis episodes in a triple-blind prospective crossover permuted block randomizing method. Clinical efficacy scale score and in vivo recovery of factor VIII was assessed in each of the treated bleeding episodes. Any adverse event was also recorded. Results: The mean±SD level of factor VIII in the plasma versus recombinant groups was 111.5±39 and 115±39, respectively without any significant difference. Response scaling method which assessed pain and range of motion revealed equalized scores along with in vivo recovery, hence treatment success rate was comparable in both groups. One non-recurring, mild skin rash reaction occurred simultaneous with the administration of plasma derived factor. Conclusion: Safacto (r-FVIII) is safe and effective and non-inferior to plasma derived factor VIII in the treatment of hemophilia A related bleeding events." @default.
- W1787686503 created "2016-06-24" @default.
- W1787686503 creator A5023108791 @default.
- W1787686503 creator A5029890058 @default.
- W1787686503 creator A5033437130 @default.
- W1787686503 creator A5037153641 @default.
- W1787686503 creator A5073867762 @default.
- W1787686503 creator A5074691586 @default.
- W1787686503 creator A5078007832 @default.
- W1787686503 creator A5087510072 @default.
- W1787686503 date "2015-07-10" @default.
- W1787686503 modified "2023-10-16" @default.
- W1787686503 title "A prospective Crossover Triple-blind Controlled Trial on the Safety and Efficacy of Iranian Recombinant FVIII (Safacto) versus Plasma Derived FVIII A pilot study" @default.
- W1787686503 cites W1501619595 @default.
- W1787686503 cites W1527938269 @default.
- W1787686503 cites W1821884670 @default.
- W1787686503 cites W1974965024 @default.
- W1787686503 cites W1991223023 @default.
- W1787686503 cites W1994744646 @default.
- W1787686503 cites W2002251042 @default.
- W1787686503 cites W2003195332 @default.
- W1787686503 cites W2011753037 @default.
- W1787686503 cites W2035920001 @default.
- W1787686503 cites W2049799808 @default.
- W1787686503 cites W2069644136 @default.
- W1787686503 cites W2076831113 @default.
- W1787686503 cites W2086739531 @default.
- W1787686503 cites W2106536550 @default.
- W1787686503 cites W2112961788 @default.
- W1787686503 cites W2142960568 @default.
- W1787686503 cites W2153177348 @default.
- W1787686503 cites W2337290468 @default.
- W1787686503 cites W2387645273 @default.
- W1787686503 hasPublicationYear "2015" @default.
- W1787686503 type Work @default.
- W1787686503 sameAs 1787686503 @default.
- W1787686503 citedByCount "1" @default.
- W1787686503 countsByYear W17876865032020 @default.
- W1787686503 crossrefType "journal-article" @default.
- W1787686503 hasAuthorship W1787686503A5023108791 @default.
- W1787686503 hasAuthorship W1787686503A5029890058 @default.
- W1787686503 hasAuthorship W1787686503A5033437130 @default.
- W1787686503 hasAuthorship W1787686503A5037153641 @default.
- W1787686503 hasAuthorship W1787686503A5073867762 @default.
- W1787686503 hasAuthorship W1787686503A5074691586 @default.
- W1787686503 hasAuthorship W1787686503A5078007832 @default.
- W1787686503 hasAuthorship W1787686503A5087510072 @default.
- W1787686503 hasConcept C104317684 @default.
- W1787686503 hasConcept C126322002 @default.
- W1787686503 hasConcept C142724271 @default.
- W1787686503 hasConcept C150903083 @default.
- W1787686503 hasConcept C185592680 @default.
- W1787686503 hasConcept C188816634 @default.
- W1787686503 hasConcept C197934379 @default.
- W1787686503 hasConcept C204787440 @default.
- W1787686503 hasConcept C207001950 @default.
- W1787686503 hasConcept C27081682 @default.
- W1787686503 hasConcept C2778570526 @default.
- W1787686503 hasConcept C2778961111 @default.
- W1787686503 hasConcept C2779394231 @default.
- W1787686503 hasConcept C40767141 @default.
- W1787686503 hasConcept C42219234 @default.
- W1787686503 hasConcept C55493867 @default.
- W1787686503 hasConcept C71924100 @default.
- W1787686503 hasConcept C86803240 @default.
- W1787686503 hasConcept C87813604 @default.
- W1787686503 hasConcept C89560881 @default.
- W1787686503 hasConcept C90924648 @default.
- W1787686503 hasConcept C98274493 @default.
- W1787686503 hasConceptScore W1787686503C104317684 @default.
- W1787686503 hasConceptScore W1787686503C126322002 @default.
- W1787686503 hasConceptScore W1787686503C142724271 @default.
- W1787686503 hasConceptScore W1787686503C150903083 @default.
- W1787686503 hasConceptScore W1787686503C185592680 @default.
- W1787686503 hasConceptScore W1787686503C188816634 @default.
- W1787686503 hasConceptScore W1787686503C197934379 @default.
- W1787686503 hasConceptScore W1787686503C204787440 @default.
- W1787686503 hasConceptScore W1787686503C207001950 @default.
- W1787686503 hasConceptScore W1787686503C27081682 @default.
- W1787686503 hasConceptScore W1787686503C2778570526 @default.
- W1787686503 hasConceptScore W1787686503C2778961111 @default.
- W1787686503 hasConceptScore W1787686503C2779394231 @default.
- W1787686503 hasConceptScore W1787686503C40767141 @default.
- W1787686503 hasConceptScore W1787686503C42219234 @default.
- W1787686503 hasConceptScore W1787686503C55493867 @default.
- W1787686503 hasConceptScore W1787686503C71924100 @default.
- W1787686503 hasConceptScore W1787686503C86803240 @default.
- W1787686503 hasConceptScore W1787686503C87813604 @default.
- W1787686503 hasConceptScore W1787686503C89560881 @default.
- W1787686503 hasConceptScore W1787686503C90924648 @default.
- W1787686503 hasConceptScore W1787686503C98274493 @default.
- W1787686503 hasIssue "4" @default.
- W1787686503 hasLocation W17876865031 @default.
- W1787686503 hasOpenAccess W1787686503 @default.
- W1787686503 hasPrimaryLocation W17876865031 @default.
- W1787686503 hasRelatedWork W1483599251 @default.
- W1787686503 hasRelatedWork W1497403991 @default.
- W1787686503 hasRelatedWork W1566919421 @default.